BACKGROUND: Diabetes mellitus is a major risk factor for coronary heart disease (CHD), renal failure, retinopathy, and neuropathy. Lowering glycosylated hemoglobin (HbA1c) as well as low-density lipoprotein-cholesterol (LDL-C) has been associated with a decreased risk of these complications. We evaluated the utility of glycated albumin (GA) and direct LDL-C, 2 novel assay, as compared to HbA1c and calculated LDL-C, in evaluating diabetes control and lipid in a heterogeneous population and in specific subgroups of patients with type 2 diabetes mellitus. METHODS: We obtained fasting blood samples and measured HbA1c, GA, and direct LDL-C, as well as other parameters, in a multi-ethnic population of 616 male and female patients with type 2 diabetes and 895 non-diabetic controls. RESULTS: HbA1c and GA levels, which measure different periods of glycemia, had a correlation of r=0.70 (p<0.001), and mean values in patients were 38.7% and 43.4% higher, respectively, than controls in men, and 41.1% and 40.1% higher, respectively, than controls, in women (both p<0.001). Calculated and direct LDL-C values correlated very highly (r=0.96, p<0.001). The correlations between HbA1c and GA, and between calculated and direct LDL-C were similar for subgroups defined by gender, race, age, and other factors. CONCLUSIONS: Calculated LDL-C provides an accurate assessment of fasting LDL-C compared with a direct measurement in most subjects, except for those with hypertriglyceridemia, and GA correlates with HbA1c in diabetic and non-diabetic subjects and may serve as a reasonable marker of short term diabetic control.
BACKGROUND:Diabetes mellitus is a major risk factor for coronary heart disease (CHD), renal failure, retinopathy, and neuropathy. Lowering glycosylated hemoglobin (HbA1c) as well as low-density lipoprotein-cholesterol (LDL-C) has been associated with a decreased risk of these complications. We evaluated the utility of glycated albumin (GA) and direct LDL-C, 2 novel assay, as compared to HbA1c and calculated LDL-C, in evaluating diabetes control and lipid in a heterogeneous population and in specific subgroups of patients with type 2 diabetes mellitus. METHODS: We obtained fasting blood samples and measured HbA1c, GA, and direct LDL-C, as well as other parameters, in a multi-ethnic population of 616 male and female patients with type 2 diabetes and 895 non-diabetic controls. RESULTS:HbA1c and GA levels, which measure different periods of glycemia, had a correlation of r=0.70 (p<0.001), and mean values in patients were 38.7% and 43.4% higher, respectively, than controls in men, and 41.1% and 40.1% higher, respectively, than controls, in women (both p<0.001). Calculated and direct LDL-C values correlated very highly (r=0.96, p<0.001). The correlations between HbA1c and GA, and between calculated and direct LDL-C were similar for subgroups defined by gender, race, age, and other factors. CONCLUSIONS: Calculated LDL-C provides an accurate assessment of fasting LDL-C compared with a direct measurement in most subjects, except for those with hypertriglyceridemia, and GA correlates with HbA1c in diabetic and non-diabetic subjects and may serve as a reasonable marker of short term diabetic control.
Authors: Ernst J Schaefer; Judith R McNamara; Timothy Tayler; Jennifer A Daly; Joi L Gleason; Leo J Seman; Andrea Ferrari; Joel J Rubenstein Journal: Am J Cardiol Date: 2004-01-01 Impact factor: 2.778
Authors: E J Schaefer; M C Audelin; J R McNamara; P K Shah; T Tayler; J A Daly; J L Augustin; L J Seman; J J Rubenstein Journal: Am J Cardiol Date: 2001-11-15 Impact factor: 2.778
Authors: Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller Journal: Lancet Date: 2004 Aug 21-27 Impact factor: 79.321
Authors: Ernst J Schaefer; Judith R McNamara; Timothy Tayler; Jennifer A Daly; Joi A Gleason; Leo J Seman; Andrea Ferrari; Joel J Rubenstein Journal: Am J Cardiol Date: 2002-10-01 Impact factor: 2.778
Authors: Jose M de Miguel-Yanes; Alisa K Manning; Peter Shrader; Jarred B McAteer; Anuj Goel; Anders Hamsten; Caroline S Fox; Jose C Florez; Josée Dupuis; James B Meigs Journal: Obesity (Silver Spring) Date: 2011-06-02 Impact factor: 5.002
Authors: N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi Journal: Diabetologia Date: 2011-09-27 Impact factor: 10.122
Authors: Esther Y Lee; Peter T Klementowicz; Robert A Hegele; Bela F Asztalos; Ernst J Schaefer Journal: J Clin Lipidol Date: 2012-11-17 Impact factor: 4.766
Authors: Ji Woo Lee; Hyung Jin Kim; Young Se Kwon; Yong Hoon Jun; Soon Ki Kim; Jong Weon Choi; Ji Eun Lee Journal: Ann Pediatr Endocrinol Metab Date: 2013-12-31
Authors: Nuntakorn Thongtang; Masumi Ai; Seiko Otokozawa; Thomas V Himbergen; Bela F Asztalos; Katsuyuki Nakajima; Evan Stein; Peter H Jones; Ernst J Schaefer Journal: Am J Cardiol Date: 2011-02-01 Impact factor: 2.778